V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017160 | 220020871 | 1.9 | 83.6 | Curative (C) | 2015-05-31 | 2015-08-08 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028912 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017163 | 220021888 | 1.66 | null | Curative (C) | 2013-11-09 | 2014-11-09 | Rituximab | 02 | null | 220028936 | RITUXIMAB |
| 220017164 | 220007489 | 1.55 | 69.7 | Curative (C) | 2013-12-20 | 2013-12-21 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028943 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017167 | 220007497 | 1.78 | 83.3 | Disease modification (D) | 2016-09-22 | 2016-09-25 | Dasatinib | N | N | 220028965 | DASATINIB |
| 220017168 | 220007501 | 1.61 | 106 | Curative (C) | 2016-10-18 | 2016-10-18 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028971 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017169 | 220007501 | 1.88 | 83.7 | Disease modification (D) | 2016-08-06 | 2016-10-06 | Rituximab | N | N | 220028971 | RITUXIMAB |
| 220017170 | 220007503 | 1.77 | null | Curative (C) | 2014-02-28 | 2014-09-27 | Dasatinib | N | N | 220028977 | DASATINIB |
| 220017171 | 220014132 | 1.5 | null | Curative (C) | 2014-02-06 | 2014-02-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028983 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017172 | 220007506 | 1.8 | 127 | Curative (C) | 2018-10-21 | 2018-10-21 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028988 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017173 | 220007508 | 1.7 | 51.5 | Neo-adjuvant (N) | 2014-09-30 | 2014-11-16 | AML18 PILOT TRIAL | Y | N | 220028990 | PILOT TRIAL |
| 220017174 | 220007515 | 1.75 | null | Curative (C) | 2015-01-15 | 2015-05-02 | AML 18 TRIAL | N | N | 220028997 | AML18 TRIAL |
| 220017175 | 220007516 | 1.7 | 49.5 | Curative (C) | 2018-03-14 | 2018-03-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028997 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017176 | 220014138 | 1.64 | null | Palliative (P) | 2018-07-17 | 2018-07-17 | Dasatinib | N | Y | 220029012 | DASATINIB |
| 220017178 | 220007525 | 1.68 | 78.1 | Curative (C) | 2015-04-26 | 2016-01-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029034 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017179 | 220007527 | null | 65.7 | Curative (C) | 2018-09-28 | 2018-09-29 | Rituximab | N | N | 220029041 | RITUXIMAB |
| 220017180 | 220007527 | 1.6 | 0 | Disease modification (D) | 2017-07-18 | 2017-07-18 | Dasatinib | N | N | 220029041 | DASATINIB |
| 220017184 | 220014149 | 1.75 | null | Disease modification (D) | 2014-01-14 | 2014-01-14 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220029081 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017185 | 220014149 | 1.69 | 95.4 | Curative (C) | 2017-04-25 | 2017-05-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029081 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017186 | 220007538 | null | 64.2 | Palliative (P) | 2015-02-14 | 2015-02-15 | Dasatinib | N | N | 220029091 | DASATINIB |
| 220017187 | 220007543 | 1.67 | 84 | Curative (C) | null | 2014-11-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029096 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017188 | 220007544 | null | 55 | Disease modification (D) | 2018-09-03 | 2018-10-23 | AML 18 Pilot Trial | 99 | null | 220029098 | PILOT TRIAL |
| 220017189 | 220014152 | 1.72 | 84 | Disease modification (D) | 2015-02-17 | 2016-01-23 | Dasatinib | null | null | 220029102 | DASATINIB |
| 220017190 | 220007547 | 0 | 62 | Curative (C) | 2013-12-11 | 2014-02-18 | AML 18 TRIAL | 1 | N | 220029109 | AML18 TRIAL |
| 220017191 | 220007548 | 1.6 | 98.9 | Curative (C) | 2017-07-28 | 2017-09-17 | AML 18 TRIAL | 1 | N | 220029118 | AML18 TRIAL |
| 220017192 | 220007550 | 1.61 | 44.3 | Curative (C) | 2014-04-18 | 2014-06-06 | AML 18 TRIAL | Y | null | 220029122 | AML18 TRIAL |
| 220017195 | 220007561 | null | 59.9 | Curative (C) | 2017-11-11 | 2017-12-15 | AML18 PILOT TRIAL | N | null | 220029155 | PILOT TRIAL |
| 220017196 | 220017721 | 1.55 | 90.6 | Curative (C) | 2018-09-13 | 2018-09-19 | Rituximab | 2 | N | 220029163 | RITUXIMAB |
| 220017197 | 220017721 | 1.66 | 47 | Curative (C) | 2015-03-01 | 2015-03-08 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220029163 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017199 | 220007567 | 0 | 61.1 | Curative (C) | 2016-02-02 | 2016-11-27 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | null | 220029179 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017200 | 220007569 | 1.66 | 92.8 | Disease modification (D) | 2013-12-20 | 2016-01-15 | Dasatinib | null | N | 220029188 | DASATINIB |
| 220017201 | 220014167 | null | null | Curative (C) | 2017-07-20 | 2017-07-21 | Dasatinib | N | null | 220029191 | DASATINIB |
| 220017202 | 220007576 | null | 77 | Disease modification (D) | 2015-03-03 | 2015-07-20 | Rituximab | N | N | 220029232 | RITUXIMAB |
| 220017203 | 220007577 | 1.66 | 74.4 | Curative (C) | 2013-04-11 | 2013-05-03 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | null | 220029235 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017204 | 220007579 | null | 61.6 | Disease modification (D) | 2018-11-14 | 2019-03-18 | Dasatinib | N | N | 220029242 | DASATINIB |
| 220017205 | 220007582 | 1.7 | null | Disease modification (D) | 2017-07-01 | 2017-07-01 | Dasatinib | 2 | N | 220029268 | DASATINIB |
| 220017206 | 220007584 | 1.7 | 97 | Disease modification (D) | 2013-04-13 | 2015-06-30 | Dasatinib | 2 | N | 220029273 | DASATINIB |
| 220017207 | 220007584 | null | 0 | Curative (C) | 2017-02-21 | 2017-04-14 | Dasatinib | 2 | N | 220029273 | DASATINIB |
| 220017208 | 220007587 | 1.6 | 0 | Curative (C) | 2017-08-11 | 2017-08-12 | Dasatinib | N | N | 220029292 | DASATINIB |
| 220017209 | 220007591 | null | 73 | Disease modification (D) | 2014-08-22 | 2014-09-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029309 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017210 | 220007593 | 0 | 50 | Curative (C) | 2016-01-10 | 2016-02-13 | Rituximab | 02 | N | 220029319 | RITUXIMAB |
| 220017211 | 220007595 | 1.66 | 0 | Curative (C) | 2018-08-31 | 2018-08-31 | AML18 PILOT TRIAL | N | N | 220029327 | PILOT TRIAL |
| 220017212 | 220007600 | 0 | 27.25 | Curative (C) | 2017-02-25 | 2017-02-25 | Rituximab | N | N | 220029334 | RITUXIMAB |
| 220017213 | 220017736 | 1.66 | null | Curative (C) | 2018-08-01 | 2018-08-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029342 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017214 | 220014185 | 1.75 | 84 | Curative (C) | 2019-05-21 | 2019-06-21 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029362 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017215 | 220007604 | null | null | Palliative (P) | 2013-11-24 | 2013-12-04 | Dasatinib | 2 | N | 220029364 | DASATINIB |
| 220017216 | 220017738 | 1.62 | 68 | Curative (C) | 2013-04-24 | 2013-04-24 | AML 18 TRIAL | 01 | N | 220029388 | AML18 TRIAL |
| 220017217 | 220007607 | 0 | 55.1 | Curative (C) | 2013-10-17 | 2013-10-17 | Dasatinib | 2 | N | 220029391 | DASATINIB |
| 220017218 | 220017739 | 0 | 65.7 | Disease modification (D) | 2017-09-03 | 2017-09-05 | AML 18 TRIAL | Y | N | 220029394 | AML18 TRIAL |
| 220017220 | 220007613 | 0 | 96.5 | Curative (C) | 2017-05-03 | 2017-05-08 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220029410 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017221 | 220007615 | 1.86 | 96.5 | Curative (C) | 2013-02-28 | 2013-06-15 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220029416 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |